 | • レポートコード：C-GIR20G2889 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「ナチュラルキラー細胞治療薬の世界市場2019年」は、グローバルにおけるナチュラルキラー細胞治療薬市場を展望するレポートです。ナチュラルキラー細胞治療薬のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・ナチュラルキラー細胞治療薬の市場概観 ・ナチュラルキラー細胞治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ナチュラルキラー細胞治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・ナチュラルキラー細胞治療薬の世界市場規模 ・ナチュラルキラー細胞治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・ナチュラルキラー細胞治療薬のアメリカ市場規模推移 ・ナチュラルキラー細胞治療薬のカナダ市場規模推移 ・ナチュラルキラー細胞治療薬のメキシコ市場規模推移 ・ナチュラルキラー細胞治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ナチュラルキラー細胞治療薬のドイツ市場規模推移 ・ナチュラルキラー細胞治療薬のイギリス市場規模推移 ・ナチュラルキラー細胞治療薬のロシア市場規模推移 ・ナチュラルキラー細胞治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ナチュラルキラー細胞治療薬の日本市場規模推移 ・ナチュラルキラー細胞治療薬の中国市場規模推移 ・ナチュラルキラー細胞治療薬の韓国市場規模推移 ・ナチュラルキラー細胞治療薬のインド市場規模推移 ・ナチュラルキラー細胞治療薬の東南アジア市場規模推移 ・ナチュラルキラー細胞治療薬の南米市場分析（ブラジル、アルゼンチン等） ・ナチュラルキラー細胞治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ナチュラルキラー細胞治療薬の種類別分析/販売量、売上、市場シェア（NK細胞療法、NK細胞指向性抗体） ・ナチュラルキラー細胞治療薬の用途別分析/市場規模（研究センターおよび研究所、病院、その他） ・ナチュラルキラー細胞治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ナチュラルキラー細胞治療薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Natural Killer Cells Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Natural Killer Cells Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Natural Killer Cells Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Natural Killer Cells Therapeutics market by product type and applications/end industries.
Market Segment by Companies, this report covers
Affimed
Nkarta Therapeutics
Fortress Biotech
Celgene Corporation
Nantkwest
Fate Therapeutics
Ziopharm Oncology
Innate Pharma
Glycostem Therapeutics
NKT Therapeutics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
NK Cell Therapies
NK Cell Directed Antibodies
Market Segment by Applications, can be divided into
Research Centers & Institutes
Hospitals
Others
Table of Contents
1 Natural Killer Cells Therapeutics Market Overview
1.1 Product Overview and Scope of Natural Killer Cells Therapeutics
1.2 Classification of Natural Killer Cells Therapeutics by Types
1.2.1 Global Natural Killer Cells Therapeutics Revenue Comparison by Types (2019-2024)
1.2.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Types in 2018
1.2.3 NK Cell Therapies
1.2.4 NK Cell Directed Antibodies
1.3 Global Natural Killer Cells Therapeutics Market by Application
1.3.1 Global Natural Killer Cells Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Research Centers & Institutes
1.3.3 Hospitals
1.3.4 Others
1.4 Global Natural Killer Cells Therapeutics Market by Regions
1.4.1 Global Natural Killer Cells Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Natural Killer Cells Therapeutics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Natural Killer Cells Therapeutics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Natural Killer Cells Therapeutics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Natural Killer Cells Therapeutics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Natural Killer Cells Therapeutics Status and Prospect (2014-2024)
1.5 Global Market Size of Natural Killer Cells Therapeutics (2014-2024)
2 Company Profiles
2.1 Affimed
2.1.1 Business Overview
2.1.2 Natural Killer Cells Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Affimed Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.2 Nkarta Therapeutics
2.2.1 Business Overview
2.2.2 Natural Killer Cells Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.3 Fortress Biotech
2.3.1 Business Overview
2.3.2 Natural Killer Cells Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Fortress Biotech Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.4 Celgene Corporation
2.4.1 Business Overview
2.4.2 Natural Killer Cells Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Celgene Corporation Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.5 Nantkwest
2.5.1 Business Overview
2.5.2 Natural Killer Cells Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Nantkwest Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.6 Fate Therapeutics
2.6.1 Business Overview
2.6.2 Natural Killer Cells Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Fate Therapeutics Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.7 Ziopharm Oncology
2.7.1 Business Overview
2.7.2 Natural Killer Cells Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ziopharm Oncology Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.8 Innate Pharma
2.8.1 Business Overview
2.8.2 Natural Killer Cells Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Innate Pharma Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.9 Glycostem Therapeutics
2.9.1 Business Overview
2.9.2 Natural Killer Cells Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.10 NKT Therapeutics
2.10.1 Business Overview
2.10.2 Natural Killer Cells Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 NKT Therapeutics Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Natural Killer Cells Therapeutics Market Competition, by Players
3.1 Global Natural Killer Cells Therapeutics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Natural Killer Cells Therapeutics Players Market Share
3.2.2 Top 10 Natural Killer Cells Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Natural Killer Cells Therapeutics Market Size by Regions
4.1 Global Natural Killer Cells Therapeutics Revenue and Market Share by Regions
4.2 North America Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
4.3 Europe Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
4.5 South America Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
5 North America Natural Killer Cells Therapeutics Revenue by Countries
5.1 North America Natural Killer Cells Therapeutics Revenue by Countries (2014-2019)
5.2 USA Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
5.3 Canada Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
5.4 Mexico Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
6 Europe Natural Killer Cells Therapeutics Revenue by Countries
6.1 Europe Natural Killer Cells Therapeutics Revenue by Countries (2014-2019)
6.2 Germany Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
6.3 UK Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
6.4 France Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
6.5 Russia Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
6.6 Italy Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Natural Killer Cells Therapeutics Revenue by Countries
7.1 Asia-Pacific Natural Killer Cells Therapeutics Revenue by Countries (2014-2019)
7.2 China Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
7.3 Japan Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
7.4 Korea Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
7.5 India Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
8 South America Natural Killer Cells Therapeutics Revenue by Countries
8.1 South America Natural Killer Cells Therapeutics Revenue by Countries (2014-2019)
8.2 Brazil Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
8.3 Argentina Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
8.4 Colombia Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Natural Killer Cells Therapeutics by Countries
9.1 Middle East and Africa Natural Killer Cells Therapeutics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
9.3 UAE Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
9.4 Egypt Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
9.6 South Africa Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
10 Global Natural Killer Cells Therapeutics Market Segment by Type
10.1 Global Natural Killer Cells Therapeutics Revenue and Market Share by Type (2014-2019)
10.2 Global Natural Killer Cells Therapeutics Market Forecast by Type (2019-2024)
10.3 NK Cell Therapies Revenue Growth Rate (2014-2024)
10.4 NK Cell Directed Antibodies Revenue Growth Rate (2014-2024)
11 Global Natural Killer Cells Therapeutics Market Segment by Application
11.1 Global Natural Killer Cells Therapeutics Revenue Market Share by Application (2014-2019)
11.2 Natural Killer Cells Therapeutics Market Forecast by Application (2019-2024)
11.3 Research Centers & Institutes Revenue Growth (2014-2019)
11.4 Hospitals Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Natural Killer Cells Therapeutics Market Size Forecast (2019-2024)
12.1 Global Natural Killer Cells Therapeutics Market Size Forecast (2019-2024)
12.2 Global Natural Killer Cells Therapeutics Market Forecast by Regions (2019-2024)
12.3 North America Natural Killer Cells Therapeutics Revenue Market Forecast (2019-2024)
12.4 Europe Natural Killer Cells Therapeutics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Natural Killer Cells Therapeutics Revenue Market Forecast (2019-2024)
12.6 South America Natural Killer Cells Therapeutics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Natural Killer Cells Therapeutics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Natural Killer Cells Therapeutics Picture
Table Product Specifications of Natural Killer Cells Therapeutics
Table Global Natural Killer Cells Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Natural Killer Cells Therapeutics Revenue Market Share by Types in 2018
Figure NK Cell Therapies Picture
Figure NK Cell Directed Antibodies Picture
Table Global Natural Killer Cells Therapeutics Revenue (Million USD) by Application (2014-2024)
Figure Natural Killer Cells Therapeutics Revenue Market Share by Applications in 2018
Figure Research Centers & Institutes Picture
Figure Hospitals Picture
Figure Others Picture
Table Global Market Natural Killer Cells Therapeutics Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Natural Killer Cells Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Natural Killer Cells Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Natural Killer Cells Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Natural Killer Cells Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Natural Killer Cells Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Natural Killer Cells Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Table Affimed Basic Information, Manufacturing Base and Competitors
Table Affimed Natural Killer Cells Therapeutics Type and Applications
Table Affimed Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Nkarta Therapeutics Basic Information, Manufacturing Base and Competitors
Table Nkarta Therapeutics Natural Killer Cells Therapeutics Type and Applications
Table Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Fortress Biotech Basic Information, Manufacturing Base and Competitors
Table Fortress Biotech Natural Killer Cells Therapeutics Type and Applications
Table Fortress Biotech Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table Celgene Corporation Natural Killer Cells Therapeutics Type and Applications
Table Celgene Corporation Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Nantkwest Basic Information, Manufacturing Base and Competitors
Table Nantkwest Natural Killer Cells Therapeutics Type and Applications
Table Nantkwest Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Fate Therapeutics Basic Information, Manufacturing Base and Competitors
Table Fate Therapeutics Natural Killer Cells Therapeutics Type and Applications
Table Fate Therapeutics Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Ziopharm Oncology Basic Information, Manufacturing Base and Competitors
Table Ziopharm Oncology Natural Killer Cells Therapeutics Type and Applications
Table Ziopharm Oncology Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Innate Pharma Basic Information, Manufacturing Base and Competitors
Table Innate Pharma Natural Killer Cells Therapeutics Type and Applications
Table Innate Pharma Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Glycostem Therapeutics Basic Information, Manufacturing Base and Competitors
Table Glycostem Therapeutics Natural Killer Cells Therapeutics Type and Applications
Table Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table NKT Therapeutics Basic Information, Manufacturing Base and Competitors
Table NKT Therapeutics Natural Killer Cells Therapeutics Type and Applications
Table NKT Therapeutics Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Global Natural Killer Cells Therapeutics Revenue (Million USD) by Players (2014-2019)
Table Global Natural Killer Cells Therapeutics Revenue Share by Players (2014-2019)
Figure Global Natural Killer Cells Therapeutics Revenue Share by Players in 2017
Figure Global Natural Killer Cells Therapeutics Revenue Share by Players in 2018
Figure Global Top 5 Players Natural Killer Cells Therapeutics Revenue Market Share in 2018
Figure Global Top 10 Players Natural Killer Cells Therapeutics Revenue Market Share in 2018
Figure Global Natural Killer Cells Therapeutics Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Natural Killer Cells Therapeutics Revenue (Million USD) by Regions (2014-2019)
Table Global Natural Killer Cells Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Natural Killer Cells Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Natural Killer Cells Therapeutics Revenue Market Share by Regions in 2018
Figure North America Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure Europe Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure South America Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Table North America Natural Killer Cells Therapeutics Revenue by Countries (2014-2019)
Table North America Natural Killer Cells Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Natural Killer Cells Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Natural Killer Cells Therapeutics Revenue Market Share by Countries in 2018
Figure USA Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure Canada Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure Mexico Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Table Europe Natural Killer Cells Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Europe Natural Killer Cells Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Europe Natural Killer Cells Therapeutics Revenue Market Share by Countries in 2018
Figure Germany Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure UK Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure France Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure Russia Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure Italy Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Natural Killer Cells Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Natural Killer Cells Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Natural Killer Cells Therapeutics Revenue Market Share by Countries in 2018
Figure China Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure Japan Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure Korea Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure India Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Table South America Natural Killer Cells Therapeutics Revenue by Countries (2014-2019)
Table South America Natural Killer Cells Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Natural Killer Cells Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Natural Killer Cells Therapeutics Revenue Market Share by Countries in 2018
Figure Brazil Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure Argentina Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure Colombia Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Natural Killer Cells Therapeutics Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Natural Killer Cells Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Natural Killer Cells Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Natural Killer Cells Therapeutics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure UAE Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure Egypt Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure Nigeria Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Figure South Africa Natural Killer Cells Therapeutics Revenue and Growth Rate (2014-2019)
Table Global Natural Killer Cells Therapeutics Revenue (Million USD) by Type (2014-2019)
Table Global Natural Killer Cells Therapeutics Revenue Share by Type (2014-2019)
Figure Global Natural Killer Cells Therapeutics Revenue Share by Type (2014-2019)
Figure Global Natural Killer Cells Therapeutics Revenue Share by Type in 2018
Table Global Natural Killer Cells Therapeutics Revenue Forecast by Type (2019-2024)
Figure Global Natural Killer Cells Therapeutics Market Share Forecast by Type (2019-2024)
Figure Global NK Cell Therapies Revenue Growth Rate (2014-2019)
Figure Global NK Cell Directed Antibodies Revenue Growth Rate (2014-2019)
Table Global Natural Killer Cells Therapeutics Revenue by Application (2014-2019)
Table Global Natural Killer Cells Therapeutics Revenue Share by Application (2014-2019)
Figure Global Natural Killer Cells Therapeutics Revenue Share by Application (2014-2019)
Figure Global Natural Killer Cells Therapeutics Revenue Share by Application in 2018
Table Global Natural Killer Cells Therapeutics Revenue Forecast by Application (2019-2024)
Figure Global Natural Killer Cells Therapeutics Market Share Forecast by Application (2019-2024)
Figure Global Research Centers & Institutes Revenue Growth Rate (2014-2019)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Natural Killer Cells Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Natural Killer Cells Therapeutics Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Natural Killer Cells Therapeutics Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Natural Killer Cells Therapeutics Revenue Market Forecast (2019-2024)
Figure Europe Natural Killer Cells Therapeutics Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Natural Killer Cells Therapeutics Revenue Market Forecast (2019-2024)
Figure South America Natural Killer Cells Therapeutics Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Natural Killer Cells Therapeutics Revenue Market Forecast (2019-2024)
ナチュラルキラー（NK）細胞治療薬市場：世界及び中国市場分析・予測（～2024年） Natural Killer (NK) Cell Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Natural Killer (NK) Cell Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status o…- ベッドバグ(トコジラミ)用キラー市場：世界及び中国市場分析・予測（～2024年） Bed Bug Killer Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Bed Bug Killer industry with a focus on the Chinese market. The report provides key statistics on the market status of the Bed Bug Killer manufacturers and is a va…
- 蚊キラー市場：世界及び中国市場分析・予測（～2024年） Mosquito Killer Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Mosquito Killer industry with a focus on the Chinese market. The report provides key statistics on the market status of the Mosquito Killer manufacturers and is a…
- 蚊キラーランプ市場：世界及び中国市場分析・予測（～2024年） Mosquito Killer Lamp Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Mosquito Killer Lamp industry with a focus on the Chinese market. The report provides key statistics on the market status of the Mosquito Killer Lamp manufac…
- 世界の人工多能性幹細胞（iPSC）市場予測（～2024年）：企業別、地域別、種類・用途別 Description Scope of the Report: The global Induced Pluripotent Stem Cells (iPSCs) market is valued at 74 million USD in 2018 and is expected to reach 114.9 million USD by the end of 2024, growing at a CAGR of 11.7% between 2019 and 2024. The Asia-Pacific will occupy for more market share in followi…